Italy· 048404026
QUOFENIX*10 cpr 450 mg
A medicinal product containing delafloxacina, registered in Italy by A.MENARINI IND.FARM.RIUN.Srl, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Delafloxacina
- Manufacturer
- A.MENARINI IND.FARM.RIUN.Srl
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic048404026QUOFENIX*10 cpr 450 mgEUR 1089.27
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Delafloxacina in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandQuofenix 300 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA. Menarini GmbH
- SpainQUOFENIX 300 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONA. Menarini Industrie Farmaceutiche Riunite S.R.L.
- FranceQUOFENIX 300 mg, poudre pour solution à diluer pour perfusionMENARINI ITALIE
- United KingdomQuofenix 300mg powder for concentrate for solution for infusion vialsA. Menarini Farmaceutica Internazionale SRL
- IcelandQuofenixA. Menarini Industrie Farmaceutiche Riunite Srl
- NetherlandsQuofenix 300 mg, poeder voor concentraat voor oplossing voor infusieA. Menarini Industrie Farmaceutiche Riunite S.r.l.
- SwedenQuofenix 300 mg Pulver till koncentrat till infusionsvätska, lösningA Menarini Manufacturing Logistics and Services s.r.l.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Quofenix
- Liechtenstein · Quofenix
- Norway · Quofenix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4a3a4cf5-f309-4a95-8b3c-b624400e2089 GET /v1/drugs/4a3a4cf5-f309-4a95-8b3c-b624400e2089?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 1089.27,
"source": "aifa",
"currency": "EUR",
"strength": "DELAFLOXACINA 450MG 10 UNITA' USO ORALE",
"substance": "Delafloxacina",
"equivalence_group": "MUR",
"transparency_flag": null
}See everything about delafloxacina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.